Healthcare News and Research

Latest Healthcare News and Research

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones.

19 May 2014

IFRC, IFPMA launch '4 Healthy Habits' initiative to combat noncommunicable diseases

The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.

19 May 2014

USPTO grants two additional patents to SeroVital-hgh formula

SeroVital®-hgh, the "Fountain of Youth" Formula everyone's talking about, has been making headlines ever since a group of some of the most renowned researchers in the world revealed that this oral compound is actually capable of increasing mean, endogenous, serum (blood) human growth hormone (hGH) levels by 682%. Experts everywhere — from dermatologists and obesity researchers to women's healthcare providers and even the famed Dr. Oz himself — began paying attention to this groundbreaking formula.

19 May 2014

CCHIT awards 2014 ONC HIT Certification to Mirth Connect version 3.0.1

Mirth, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a global leader in health information technology, announced today that Mirth® Connect version 3.0.1 is compliant with the ONC 2014 Edition criteria and was certified as an Electronic Health Record (EHR) Module on May 1, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Eligible Providers (Ambulatory) certification criteria adopted by the Secretary of Health and Human Services.

19 May 2014

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

KineMed, Inc. and CHDI Foundation, Inc. announced today an extension of their collaboration that uses KineMed's translational biomarker platform to characterize and track the pathogenesis of Huntington's disease (HD) and evaluate potentially therapeutic interventions.

19 May 2014

Research reports on Asian cosmetic surgery market

MarketReportsOnline.com offers "Cosmetic Surgery Market in Asia" 2014 industry research report, on South Korea, Thailand, India and Singapore, in its store.

19 May 2014

Umbian announces outcome of new study for U-Sleep automated messaging system

Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.

19 May 2014

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson's Diagnostics VivoSight system.

19 May 2014

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that results from a real-life, retrospective, observational study of QVAR- will be presented at the American Thoracic Society (ATS) 2014 International Conference in San Diego on May 18, 2014.

19 May 2014

Vitamin D shown to have limited benefit for asthma

Adding vitamin D to asthma treatment to improve breathing only appears to benefit patients who achieve sufficient levels of the supplement in the blood. Overall, the ability to control asthma did not differ between a study group that received vitamin D supplements and a group that received placebo, according to new research at Washington University School of Medicine in St. Louis.

19 May 2014

IAVI: Together, we can achieve a world without AIDS

Do you remember the world before HIV/AIDS? Where will you be when the shadow of this disease is finally gone?

19 May 2014

Study: E-cigarettes appear to increase virulence of drug- resistant and life-threatening bacteria

Despite being touted by their manufacturers as a healthy alternative to cigarettes, e-cigarettes appear in a laboratory study to increase the virulence of drug- resistant and potentially life-threatening bacteria, while decreasing the ability of human cells to kill these bacteria

19 May 2014

Painkillers may prevent repeated urinary tract infections in women, says study

Women plagued by repeated urinary tract infections may be able to prevent the infections with help from over-the-counter painkillers, new research in mice shows.

19 May 2014

Anthem Blue Cross and Blue Shield hails Gov. Pence's proposal to enhance Healthy Indiana Plan

The leaders of Anthem Blue Cross and Blue Shield's Medicaid business are hailing Governor Mike Pence's proposal to enhance the state's Healthy Indiana Plan (HIP).

17 May 2014

AirStrip wins TripleTree iAward for Connected Health

AirStrip, the leading provider of mobile healthcare solutions for driving clinical transformation, was honored today by TripleTree as part of the 6th Annual TripleTree iAwards for Connected Health.

17 May 2014

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.

16 May 2014

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of the Company's proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).

16 May 2014

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

Abbott today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets.

16 May 2014

First Edition: May 16, 2014

Today's headlines include reports about the Indiana governor's alternative plan to expand Medicaid. Kaiser Health News staff writer Sarah Varney, working in collaboration with PBS Newshour, reports: "Men and women involved in the criminal justice system are more likely to be sicker than the general population, with higher rates of diabetes, hypertension, depression, mood disorders and alcohol and drug addiction.

16 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

Healthcare News and Research

Latest Healthcare News and Research

Endo acquires worldwide rights to Zogenix' sumatriptan injection

IFRC, IFPMA launch '4 Healthy Habits' initiative to combat noncommunicable diseases

USPTO grants two additional patents to SeroVital-hgh formula

CCHIT awards 2014 ONC HIT Certification to Mirth Connect version 3.0.1

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

Research reports on Asian cosmetic surgery market

Umbian announces outcome of new study for U-Sleep automated messaging system

Study to investigate use of OCT in collaboration with Melanoma Institute of Australia

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Vitamin D shown to have limited benefit for asthma

IAVI: Together, we can achieve a world without AIDS

Study: E-cigarettes appear to increase virulence of drug- resistant and life-threatening bacteria

Painkillers may prevent repeated urinary tract infections in women, says study

Anthem Blue Cross and Blue Shield hails Gov. Pence's proposal to enhance Healthy Indiana Plan

AirStrip wins TripleTree iAward for Connected Health

OLYSIO (simeprevir) receives EC marketing authorisation for treatment of genotype 1 and 4 CHC

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

First Edition: May 16, 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in